WHERE QUALITY AND COMMITMENT MEET
Live / Applied — First extension granted (statement of use) (as of 22 Jan 2026)
What this means for you
Not registered yet, but its 15 Nov 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98856864
- Mark type
- Stylized text
- Filed
- 15 Nov 2024
- Published for opposition
- 27 May 2025
- Attorney of record
- Rhett V. Barney
Goods and services
- Class 039 — Transportation and storage services: Merchandise packaging for others; Merchandise packaging, namely, packaging of pharmaceuticals, medicines, medicaments, veterinary products for others
- Class 040 — Treatment of materials: Manufacturing services for others in the fields of biotechnology and pharmaceuticals; Manufacturing services for others of pharmaceuticals, medicines, medicaments, and the packaging for same; Custom production and processing of chemicals, ingredients for pharmaceuticals, and cells for research and scientific purposes for others; Manufacture of bacteriological cultures, buffer solution, and reagents to the order and specification of others; Custom manufacture of pharmaceuticals, medicines and medical therapies
- Class 042 — Scientific and technological services: Development of pharmaceutical preparations and medicines; Product development in the fields of biotechnology and pharmaceuticals; Product development consulting in the fields of biotechnology and pharmaceuticals; Pharmaceutical products development; Research and development in the pharmaceutical and biotechnology fields; Research and development in the field of biotechnology and pharmaceuticals; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Pharmaceutical drug development services; Pharmaceutical research and development; Scientific laboratory services; Scientific and technological services, namely, scientific research in the field of biotechnology and pharmaceuticals; Research and development of new products for others; Product development consultation; Product research and development; Scientific research and development; Design and testing for new product development
Owner
- Selkirk Pharma, Spokane, WA, US
- Selkirk Pharma, Spokane, WA, US
Prosecution history
- 23 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Jan 2026 — SOU EXTENSION 1 GRANTED
- 22 Jan 2026 — SOU EXTENSION 1 FILED
- 22 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 22 Jul 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 27 May 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 May 2025 — PUBLISHED FOR OPPOSITION
- 21 May 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 24 Apr 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 23 Apr 2025 — ASSIGNED TO EXAMINER
- 15 Nov 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 15 Nov 2024 — NEW APPLICATION ENTERED